Blog

SBI Funds Management IPO Explained: ₹9,813 Crore, Huge Demand and What Comes Next

SBI Funds Management IPO explained: explore its ₹9,813 crore OFS, huge subscription, listing, mutual fund growth opportunity, risks and investor outlook. There was a time when Indians associated investing with fixed deposits, gold and real estate. Today, millions of households invest every month through mutual funds and SIPs. That transformation has created a new kind […]

Blog

Why Retail Investors Are Replacing Foreign Investors: The Biggest Shift in Indian Stock Market

Discover how retail investors and SIPs are transforming India’s stock market, reducing dependence on FII flows, and reshaping long-term investing. For decades, one number decided the mood of Dalal Street. Foreign Institutional Investor (FII) flows. If FIIs bought Indian stocks, markets rallied. If FIIs sold, panic spread across trading terminals. But something remarkable has changed

Blog

Trump Tariffs Pause on Generic Drugs: Big Relief or Bigger Warning?

Trump’s decision to keep generic medicines tariff-free for two years offers relief to Indian pharma companies, but future tariffs could reshape global pharmaceutical trade. The global pharmaceutical industry received an unexpected breather this week. U.S. President Donald Trump announced that imported generic medicines will continue to enter the United States without tariffs for the next

Blog

Why Paytm Said No to a Bonus Issue—and Why It Matters

Paytm’s bonus issue proposal was shelved as the company chose to prioritize growth and profitability. Here’s what the decision means for investors. For weeks, the market was buzzing with one question: Will Paytm reward shareholders with its first-ever bonus issue? Many investors expected free bonus shares, believing it could boost market sentiment and improve stock

Scroll to Top